Blood clot-busting nanocapsules could reduce existing treatment’s side effects
Imperial researchers have designed drug delivery nanocapsules that could reduce the side effects of a major blood clot dissolving drug.
Key enzyme aggravates colorectal cancer in obese patients
New research suggests the enzyme CES1 helps tumour cells to survive and drives aggressive colorectal cancer in obese patients.
NHS Digital Academy recruits the next cohort of digital health leaders
A new consortium has been selected by Health Education England to deliver the NHS Digital Academy’s Digital Health Leadership programme.
New AI technology protects privacy in healthcare settings
Researchers at TUM and Imperial have developed a technology that protects patients’ personal data while training healthcare algorithms.
3
AI analytics predict COVID-19 patients’ daily trajectory in UK intensive care
Researchers used AI to identify which daily changing clinical parameters best predict intervention responses in critically ill COVID-19 patients.
Mental Health Awareness Week 10-16 May
Imperial is hosting various virtual activities for staff and students to help support our community
Key enzyme TPL-2 helps immune cells kill disease-causing bacteria
A new study sheds light on how the body’s response to bacterial infection is controlled in a key type of immune cell – the macrophage.
Novel Gold-coated SERS Filters for Diagnosis of Urinary Tract Infections
A Hamlyn-led project proposed novel gold-coated filters for diagnosis of urinary tract infections using surface enhanced Raman spectroscopy (SERS).
New study reveals weak spots in chemotherapy-resistant cancer cells
Molecular ‘weak spots' in cancer cells recovering from chemotherapy could provide the basis for better treatments, according to new research
€2.5m ERC Advanced grant to make AI more accessible for health and law
The European Research Council has awarded an Imperial College London researcher €2.5m to make AI more easily available in the areas of health and law.
